← Evidence map

ArticlePloS one2013

HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.

Juan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it

The trial

NCT02662348phase 16 enrolled2016
Full record →Abstract, authors, funding and every citing paper · PMID 24015299